» Articles » PMID: 10887488

Genetic Analysis of Breast Cancer Progression

Overview
Date 1996 Apr 1
PMID 10887488
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

At the histological level, breast tumors display a variety of morphologic lesions which suggest the existence of an increasingly aberrant pathway of intermediate steps leading to the invasive primary tumor and its metastatic dissemination. In order to obtain direct evidence for this presumed progression, underlying genetic changes must be identified. Analyses of primary breast tumors have revealed a large number of dominant and recessive gene alterations encompassing several cellular attributes and activities. It is quite likely that some of these alterations are of a causal nature and thus enable the tumor to attain distinctive malignant phenotypes, such as, dysregulated proliferation, invasion, angiogenesis, and ability to metastasize. Considerable heterogeneity has been observed in the sequence of acquisition of these genetic changes, which is substantiated by recent comparative analyses between carefully microdissected preinvasive and invasive tumor. The data are evaluated here in the context of existing models of breast cancer progression. Implication and prospects for translational application to the clinic are also discussed.

Citing Articles

Modeling the effect of tumor size in early breast cancer.

Verschraegen C, Vinh-Hung V, Cserni G, Gordon R, Royce M, Vlastos G Ann Surg. 2005; 241(2):309-18.

PMID: 15650642 PMC: 1356917. DOI: 10.1097/01.sla.0000150245.45558.a9.

References
1.
Hollingsworth R, Lee W . Tumor suppressor genes: new prospects for cancer research. J Natl Cancer Inst. 1991; 83(2):91-6. DOI: 10.1093/jnci/83.2.91. View

2.
Sato T, Akiyama F, Sakamoto G, Kasumi F, Nakamura Y . Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res. 1991; 51(21):5794-9. View

3.
Andersen T, Gaustad A, Ottestad L, Farrants G, Nesland J, Tveit K . Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas. Genes Chromosomes Cancer. 1992; 4(2):113-21. DOI: 10.1002/gcc.2870040203. View

4.
Futreal P, Soderkvist P, Marks J, Iglehart J, Cochran C, Barrett J . Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Cancer Res. 1992; 52(9):2624-7. View

5.
Ito I, Yoshimoto M, Iwase T, Watanabe S, Katagiri T, Harada Y . Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer. Br J Cancer. 1995; 71(3):438-41. PMC: 2033649. DOI: 10.1038/bjc.1995.89. View